Session » (1534–1553) Vasculitis – ANCA-Associated Poster II: Epidemiology, Outcomes, & Classification
-
Abstract Number: 1534
ANCA-associated Vasculitis Incidence in a Norther Spanish Health Region
-
Abstract Number: 1535
Epidemiology and Treatment Outcome of ANCA-associated Vasculitis in South Korea: A Nationwide, Population-based Cohort Study
-
Abstract Number: 1536
The Impact of COVID-19 Vaccination on ANCA Vasculitis Hospitalisations: A Perspective from Sydney Australia
-
Abstract Number: 1537
Long-term Observational Study of Interstitial Lung Disease in ANCA-associated Vasculitis
-
Abstract Number: 1538
Large Vessel Involvement in Antineutrophil Cytoplasmic Antibody- Associated Vasculitis: A Single Center Experience over Two Decades
-
Abstract Number: 1539
Digital Ischemia, a Rare Manifestation in Anti-neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis (AAV)
-
Abstract Number: 1542
The Burden of Multimorbidity in ANCA-Associated Vasculitis: A Cohort Study
-
Abstract Number: 1543
The Association of Frailty with Outcomes in Patients with Vasculitis
-
Abstract Number: 1544
Increased Risk of Severe Infection in Patients with Antineutrophil Cytoplasmic Antibody-associated Vasculitides: A Population-based Trend Analysis
-
Abstract Number: 1545
Validation of the 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria in Patients with ANCA-associated Vasculitis
-
Abstract Number: 1546
Eosinophilic Granulomatosis with Polyangiitis: Clinical Suspicion Red Flags Identification by a Systematic Literature Review and Multidisciplinary Expert Consensus
-
Abstract Number: 1547
Disease Burden of Eosinophilic Granulomatosis with Polyangiitis (EGPA): A Retrospective Analysis of US Health Insurance Claims Data
-
Abstract Number: 1548
Diagnosis Pathways in Patients with Eosinophilic Granulomatosis with Polyangiitis (EGPA): A Retrospective Analysis of US Health Insurance Claims Data
-
Abstract Number: 1549
Treatment Patterns for Eosinophilic Granulomatosis with Polyangiitis (EGPA): A Retrospective Analysis of US Health Insurance Claims Data
-
Abstract Number: 1550
Importance of Shared Decision-Making for Patients with ANCA-Associated Vasculitis
-
Abstract Number: 1551
Measurement of Sinonasal Disease Activity in Granulomatosis with Polyangiitis
-
Abstract Number: 1552
Epidemiology and Outcome of Eosinophilic Granulomatosis with Polyangiitis in France
-
Abstract Number: 1553
Central Nervous System Involvement and Mimickers in ANCA Associated Vasculitis